CNBC Daily Open: Buzz words of the day — tech, AI, crypto

3 Min Read

Losing steam?Wall Street showed signs of losing steam Tuesday after a blistering rally last month, as two of its three main indexes ended lower for a second straight day. The Dow Jones Industrial Average fell 0.22%, while the S&P 500 inched down 0.06%. The Nasdaq Composite added 0.31% as technology shares advanced. Asia-Pacific markets rebounded Wednesday, led by Japan’s Nikkei 225 which soared 2.04%. The most valuable Apple Apple’s market capitalization crossed $3 trillion for the first time since August. The iPhone maker climbed 2% to $193.42 per share on Tuesday and remains the most valuable publicly traded U.S. company. It officially surpassed the $3 trillion mark for the first time in June, and briefly touched the level on an intraday basis in December 2022. The company’s stock price has risen over 48% so far this year. X.AI fundraiseElon Musk’s artificial intelligence startup X.AI has filed with the SEC to raise up to $1 billion in an equity offering. It has so far raised nearly $135 million from four investors, with the first sale occurring on Nov. 29. Goldilocks’ porridge Job openings, a barometer of employer demand for workers, fell by 617,000 to 8.7 million in October, the lowest since March 2021, the U.S. Department of Labor reported Tuesday in a survey. Economists said the U.S. economy was now inching closer to a so-called “soft landing” after recent batches of better-than-expected data. Bitcoin bull runBitcoin topped $44,000 for the first time since April 2022 on Tuesday. The price of the world’s biggest cryptocurrency was last up more than 4% at $43,794.99, according to Coin Metrics, extending gains from the previous day. The digital coin is now up more than 160% for the year. [PRO] Eli Lilly vs. Novo Nordisk It has been quite a year for both Eli Lilly and Novo Nordisk given the boom in weight-loss drugs. Stocks of both pharmaceutical companies have rallied this year. Shares in Eli Lilly are up around 60% year-to-date, while its Danish counterpart Novo Nordisk has gained about 50%. Here’s the full story.

Share This Article
By admin
test bio
Leave a comment
Please login to use this feature.